portfolio? Well, you are in the right place right now as I will take you through some of the analytical overview of pharmaceuticals companies in the U.S. Using the example of Pfizer along with Merck ( MRK ) , Novartis AG ( NVS ) and Sanofi
By Shane Blackmon : Synergy Pharmaceuticals ( SGYP ) is looking to make a name for itself in an un-sexy but lucrative market. Synergy's lead product, Plecanatide, is
that the bad news or worse is fully priced into the stock and quite often marks the bottom for the equity. Teva Pharmaceuticals ( TEVA ) is the company in question and given its low valuation, it is an ideal time to start to bottom fish in
By Richard Cavalli : The shares of Ampio Pharmaceuticals ( AMPE ) have been on a fairly steady decline since last December when they broke down in the mid 7's but they have not been
Watson Pharmaceuticals ( WPI +2.8% ) gains on an upgrade to Outperform on valuation at Wells Fargo. Wells says that on deeper analysis, it has higher
SHANGHAI, May 24 (Reuters) - Shanghai Pharmaceuticals Holding said on Thursday it has not received notification from regulators in China and Hong Kong that it was under investigation over its its finances.
By ValueMax : The pharmaceuticals industry is a defense play, just like the food and beverages industry, in terms of sensitivity and market beta. Abbott Laboratories
their trials and drugs targeting and related to Leukemia patients. They are Pharmacyclics ( PCYC ) and Threshold Pharmaceuticals ( THLD ). Lets briefly review our findings: Pharmacyclics According to recent data released from a clinical trial
By VFC : Shares of NovaBay Pharmaceuticals ( NBY ) were cruising along for months in a price range pretty much centered at right around the $1.30 mark until a sudden slide
By VFC : Synergy Pharmaceuticals ( SGYP ) ran to over seven dollars last month on increasing ..... also received a boost when its chief competitor, Ironwood Pharmaceuticals ( IRWD ) received a setback at the FDA that allows SGYP an